Almac Group, a global contract development and manufacturing organization, has appointed two new vice presidents at its Craigavon and Souderton headquarter facilities.

Dr. John Robson has been appointed vice president of quality operations at its sciences’ business unit based in the U.K., which offers API and chemical development services for all stages of drug development. He will be responsible for the operation of the analytical services business and overseeing quality across their sites located throughout the U.K. and U.S. In addition to his direct operational responsibilities, he also will be an integral member of the senior leadership team, focusing on strategy development and implementation to expand and grow their global operations.

With over 20 years of experience in a number of business leadership, quality and analytical roles Robson joins Almac directly from Lonza Biologics, where he was global head of analytical services. Previously, he was vice president and general manager, early development at covance, and global head of bioanalytical services at MDS Pharma Services.

George Tiger has been appointed vice president of global business development at Almac’s Clinical Technologies based in Souderton, Pa., and is responsible for commercial operations and business development.

Previously, Tiger held the position of senior vice president, life sciences sales for health market science where he was responsible for the sales efforts across the life sciences industry. Prior to this, his experience includes over 12 years with ERT, a supplier of cardiac safety, respiratory and eCOA solutions, where he served in a series of management positions of increasing responsibility in the U.S., Europe and globally.

With over 25 years’ experience in the field, he began his career with Abbott Laboratories, diagnostics division.